CELEX: 62015TA0214
Language: en
Date: 2017-11-06 00:00:00
Title: Case T-214/15: Judgment of the General Court of 21 September 2017 — Novartis v EUIPO — Meda (Zymara) (EU trade mark — Opposition proceedings — Application for the EU word mark Zymara — Earlier EU word mark FEMARA — Relative ground for refusal — Article 8(1)(b) of Regulation (EC) No 207/2009 — Article 75 of Regulation No 207/2009 — Article 76(1) of Regulation No 207/2009)

6.11.2017   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 374/26
            
         Judgment of the General Court of 21 September 2017 — Novartis v EUIPO — Meda (Zymara)
   (Case T-214/15) (1)
   
   ((EU trade mark - Opposition proceedings - Application for the EU word mark Zymara - Earlier EU word mark FEMARA - Relative ground for refusal - Article 8(1)(b) of Regulation (EC) No 207/2009 - Article 75 of Regulation No 207/2009 - Article 76(1) of Regulation No 207/2009))
   (2017/C 374/39)
   Language of the case: English
   
      Parties
   
   
      Applicant: Novartis AG (Basle, Switzerland) (represented by M. Douglas, lawyer)
   
      Defendant: European Union Intellectual Property Office (represented by H. O’Neill, acting as Agent)
   
      Other party to the proceedings before the Board of Appeal of EUIPO: Meda AB (Solna, Sweden)
   
      Re:
   
   Action brought against the decision of the Fifth Board of Appeal of EUIPO of 6 February 2015 (Case R 550/2014-5) relating to opposition proceedings between Novartis and Meda.
   
      Operative part of the judgment
   
   The Court:
   
               1.
            
            
               Dismisses the action;
            
         
               2.
            
            
               Orders Novartis AG to pay the costs.
            
         
      (1)  OJ C 205, 22.6.2015.